PCM
CME icon

Prelude Capital Management’s CME Group CME Stock Holding History

Prelude Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,000
Closed -$3.17M – 1954
2019
Q3 		$3.17M Buy
+15,000
New +$3.13M 0.14% 98
2019
Q2 		– Sell
-5,000
Closed -$823K – 1733
2019
Q1 		$823K Buy
+5,000
New +$884K 0.05% 374

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Prelude Capital Management's CME Position: Q2 2026 in Review

Prelude Capital Management increased its CME Group (CME) stake by 225% in Q2 2026, buying an estimated $607K and bringing the position to 3,169 shares worth $700K. The position accounts for 0.05% of the portfolio, ranked #410.

Prelude Capital Management first reported a position in CME in Q1 2015 and has held it in 24 quarters since. The position peaked at $4.3M in Q3 2018. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Prelude Capital Management held 3,169 shares of CME Group worth $700K as of Q2 2026.
  • Prelude Capital Management bought 2,193 CME Group shares in Q2 2026, an estimated $607K.
  • CME Group made up 0.05% of Prelude Capital Management's portfolio in Q2 2026, its #410 holding.
  • Prelude Capital Management first reported a position in CME Group in Q1 2015 and has held it in 24 quarters since.
  • Prelude Capital Management's CME Group position peaked at $4.3M in Q3 2018.
  • 1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.